carboplatin-Taxol-bevacizumab regimen

Definition / meaning of carboplatin-Taxol-bevacizumab regimen

A chemoimmunotherapy regimen consisting of carboplatin, paclitaxel (Taxol) and bevacizumab used for the treatment of advanced-stage, nonsquamous non-small cell lung cancer. (NCI Thesaurus)

Listed under:

Find More About 'carboplatin-Taxol-bevacizumab regimen'

Source(s):

The Web site of the National Cancer Institute (http://www.cancer.gov/)

Leave a Comment

*

This site uses Akismet to reduce spam. Learn how your comment data is processed.